Literature DB >> 27173604

A Pathway Through the Bundle Jungle.

Blase Polite1, Jeffery C Ward1, John V Cox1, Roscoe F Morton1, John Hennessy1, Ray Page1, Rena M Conti2.   

Abstract

Mesh：

Year:  2016        PMID： 27173604     DOI： 10.1200/JOP.2015.008789

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  6 in total

1.  Diffusion of Bevacizumab Across Oncology Practices: An Observational Study.

Authors:  Nancy L Keating; Haiden A Huskamp; Deborah Schrag; John M McWilliams; Barbara J McNeil; Bruce E Landon; Michael E Chernew; Sharon-Lise T Normand
Journal:  Med Care       Date:  2018-01       Impact factor: 2.983

2.  No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations.

Authors:  Bobby Daly; Andrew Hantel; Kristen Wroblewski; Jay S Balachandran; Selina Chow; Rebecca DeBoer; Gini F Fleming; Olwen M Hahn; Justin Kline; Hongtao Liu; Bhakti K Patel; Anshu Verma; Leah J Witt; Mayumi Fukui; Aditi Kumar; Michael D Howell; Blase N Polite
Journal:  J Oncol Pract       Date:  2016-10       Impact factor: 3.840

3.  Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia.

Authors:  Rudy S Suidan; Weiguo He; Charlotte C Sun; Hui Zhao; Nicole D Fleming; Pedro T Ramirez; Pamela T Soliman; Shannon N Westin; Karen H Lu; Sharon H Giordano; Larissa A Meyer
Journal:  Gynecol Oncol       Date:  2017-01-26       Impact factor: 5.482

4.  Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings.

Authors:  Po-Hung Hsieh; Alec J Kacew; Marie Dreyer; Anthony V Serritella; Randall W Knoebel; Garth W Strohbehn; Mark J Ratain
Journal:  NPJ Breast Cancer       Date:  2022-03-14

5.  Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.

Authors:  Bobby Daly; Olufunmilayo I Olopade; Ningqi Hou; Katharine Yao; David J Winchester; Dezheng Huo
Journal:  JAMA Oncol       Date:  2017-07-01       Impact factor: 31.777

6.  Utilization of Clinical Pathways Can Reduce Drug Spend Within the Oncology Care Model.

Authors:  Andrew Hertler; Sang Chau; Rani Khetarpal; Ed Bassin; Jeff Dang; Daniel Koppel; Vijay Damarla; James Wade
Journal:  JCO Oncol Pract       Date:  2020-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.